The Real Reason Pot Stocks Have Plunged

The cannabis sector is slumping because the industry giants, Aurora Cannabis Inc. (TSX:ACB)(NYSE:ACB) and Canopy Growth Corp (TSX:WEED)(NYSE:CGC), are both struggling with different issues.

| More on:
Businessman looking at a red arrow crashing through the floor

Image source: Getty Images.

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

If the scandals and controversies in the marijuana industry aren’t enough, the shares of the two largest cannabis companies are plummeting. If the downtrend continues, will the entire industry collapse?

In the last two months, Canopy (TSX:WEED)(NYSE:CGC) has fallen by 38%. Aurora (TSX:ACB)(NYSE:ACB) has dropped by 24%. The industry giants are losing steam, while investors’ interest is clearly fading.

Ruptured image

Canopy was supposed to be the prime weed stock following the partnership with American beverage giant Constellation Brands. But things got ugly in July. Bruce Linton, the company’s co-founder, was kicked out. The principal investor didn’t like the mounting losses and excessive spending by the long-time CEO.

The fiscal first-quarter 2020 results for the period ended June 30, 2019, presented in mid-August, revealed the truth. Canopy lost $1.28 billion coming from a $91 million loss in fiscal Q1 2019. And the backlash is continuing for the headless cannabis company.

Canopy is in a bind. The sizable loss brought down the company’s market capitalization, which stands at $11.5 billion to date. If the pace of expenditures doesn’t slow down, Canopy’s treasure chest might dry out sooner rather than later. The M&A activities accounted for 59% of the enormous losses.

Rumours are circulating that Bruce Linton is buying shares of Canopy or recommending a buy rating. Whether there’s truth to it or not, Canopy projects revenue to rise by 185.5% to 646.3 million in fiscal 2020 and by 87.1% to $1.21 billion in fiscal 2021.

The company’s expected net loss in fiscal 2020 is $1.38 billion in fiscal 2020 but is projected to drop to $310.7 million in fiscal 2021. For WEED, invest at your own risk.

Far from profitability

Aurora is in a precarious situation as well. The acknowledged leader in cannabis production is still too distant to be profitable. This $7.63 billion marijuana company reported a net loss of $158.4 million in the quarter ending March 31, 2019.

During the most recent conference call, Cam Battley, Aurora’s chief corporate officer, was quick to say that the company is on a “pathway to profitability.” But more likely, Aurora will realize substantial profits no sooner than its fiscal 2021 or by June 30, 2021.

The question now is whether Aurora needs a moneyed institutional partner moving forward. Strategic advisor Nelson Peltz warns against yielding majority ownership to a prominent investor. Aurora is not keen on working out a deal with any, at least not yet.

The latest development for Aurora is the push into the hemp market. The company confirmed completing its acquisition of all outstanding shares of Hempco Food and Fiber. The transaction is worth $63.4 million.

Risky investments

Investors in the cannabis space are exhausted. They’re having difficulty evaluating weed stocks.

Constellation Brands might decide to take a super-majority stake in Canopy Growth as it continues the search for a new leader.

Meanwhile, Aurora Cannabis is not selling out, nor it is ready to jump into edible marijuana and cannabis-infused beverages. But with the way things are going, weed stocks are risky investments.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Christopher Liew has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »